Over at Tech Central Station, Michael Fumento updates us on the "surprising" news that researchers are making impressive strides in adult stem cell research, and not so much in embryonic stem cell research.

[Cardiologist Douglas] Losordo bemoans the broad-based assault by ESC researchers and the media to exaggerate the potential of ESC research while downplaying or even ignoring tremendous breakthroughs in ASC work. "I don't have any personal religious or other objections to ESC research despite the vowels in my name," he says, referring to his Italian Catholic heritage. "But as a clinical investigator I have an obligation to develop therapies which appear to be of most use to my patients."

If there was a lot of promise in embryonic stem cell research, investors would be spending money on it -- instead of the taxpayers of California.